Poseida Therapeutics Inc.
9.50
0.00 (0.00%)
At close: Jan 07, 2025, 9:00 PM

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
PE Ratio -2.46 -5.96 96.15 161.02 -6.58 -12.42 -31.02 -199.02
PS Ratio 4.68 2.92 13.55K n/a n/a n/a 204.33 93.21
PB Ratio 2.92 2.03 2.71 1.51 -4.08 -7.19 -18.18 55.46
P/FCF Ratio -3.18 -12.42 -4.03 -3.03 -8.77 -14.03 -26.64 -77.18
P/OCF Ratio -3.29 -14.24 -4.13 -3.48 -9.47 -14.51 -26.87 -91.16
OCF/S Ratio -1.42 -0.21 -3.28K n/a n/a n/a -7.6 -1.02
Debt / Equity Ratio 0.71 0.47 0.39 0.13 -0.19 -0.25 -0.29 n/a
Quick Ratio 3.18 5.46 4.94 10.46 5.82 2.51 2.18 1.79
Current Ratio 3.18 5.54 4.94 10.46 5.82 2.51 2.18 1.79
Asset Turnover 0.24 0.37 0.00 n/a n/a n/a 0.12 0.35
Interest Coverage -14.94 -9.41 -42.11 -36.09 -24.07 -23.38 -35.25 n/a
Return on Equity (ROE) -1.19 -0.34 0.03 0.01 0.62 0.58 0.59 -0.28
Return on Assets (ROA) -0.45 -0.18 0.02 0.01 -0.63 -0.98 -0.77 -0.16
Return on Capital (ROIC) -0.64 -0.2 -0.00 -0.00 -0.68 -1.31 -1.08 -0.31
Dividend Yield n/a n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin -142.29% 96.03% -14.47K% n/a n/a n/a 100.00% 100.00%
Net Profit Margin -190.76% -49.1% 14.10K% n/a n/a n/a -658.69% -46.84%
Pretax Profit Margin -190.6% -48.68% -400.07% n/a n/a n/a -676.35% -54.67%
Operating Profit Margin -200.15% -45.98% -452.69% n/a n/a n/a -658.89% -55.78%
FCF Margin -147.18% -23.55% -336.70K% n/a n/a n/a -767.1% -120.77%
EBITDA Margin -168.52% -42.02% -374.75K% n/a n/a n/a -699.5% -52.42%